Back to results
CompletedPhase 2

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

NCT00501592

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Profil Institute for Clinical Research, Inc.

Chula Vista, California, United States

+3 additional locations

View on ClinicalTrials.gov
Study of INT-747 in Patients With Diabetes and Presumed NAFLD — TrialFind